计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| C646549-25mg |
25mg |
期货 ![]() |
| |
| C646549-50mg |
50mg |
期货 ![]() |
| |
| C646549-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | COH-SR4 |
| 生化机理 | COH-SR4 是一种 AMPK 激活剂。COH-SR4 对白血病、黑色素瘤、乳腺癌和肺癌有很强的抗增殖活性。COH-SR4 通过激活 AMPK 抑制脂肪细胞分化。COH-SR4 可用于肥胖及其相关疾病的研究。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
COH-SR4 is an AMPK activator. COH-SR4 shows potent anti-proliferative activities against leukemia, melanoma, breast and lung cancers. COH-SR4 inhibits adipocyte differentiation via AMPK activation. COH-SR4 can be used for the research of obesity and related metabolic disorders In Vitro COH-SR4 (1-5 μM; 24 hours) results in a dose-dependent increase in the phosphorylation of AMPK and its substrate ACC in 3T3-L1 preadipocytes, as well as in cancer cells such as HL-60, HeLa, MCF-7. COH-SR4 (3-5 µM; 7 days) significantly inhibits 3T3-L1 adipocyte differentiation in a dose-dependent manner. COH-SR4 (1-5 μM; 24 hours) promotes cell G1 cycle arrest. COH-SR4 significantly reduces intracellular lipid accumulation and downregulates the expression of key adipogenesis-related transcription factors and lipogenic proteins. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: 3T3-L1 preadipocytes, HL-60 cells, HeLa cells, MCF-7 cells Concentration: 1 μM, 3 μM, 5 μM Incubation Time: 24 hours Result: Indirectly activated AMPK. Cell Cycle AnalysisCell Line: 3T3-L1 cells Concentration: 1 μM, 3 μM, 5 μM Incubation Time: 24 hours Result: Modulated the level of proteins active during S and G2 phases of the cell cycle. In Vivo COH-SR4 (5 mg/kg; i.g.; 3x/week; for 6 weeks) reduces body weight and fat mass in high fat diet (HFD) obese mice without affecting food intake. COH-SR4 improves glycemic control and dyslipidemia in HFD obese mice. COH-SR4 decreases adipose tissue hypertrophy and affects circulating adipokine levels in HFD obese mice. COH-SR4 prevents hepatic lipid accumulation and fatty liver in HFD obese mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Nine-week old male C57BL/6J miceDosage: 5 mg/kg Administration: Oral gavage, three times a week, for 6 weeks Result: Decreased body weight and fat mass in HFD obese mice. Form:Solid IC50& Target:AMPK |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 未知 |
|---|---|
| IIUPAC Name | 1,3-bis(3,5-dichlorophenyl)urea |
| INCHI | 1S/C13H8Cl4N2O/c14-7-1-8(15)4-11(3-7)18-13(20)19-12-5-9(16)2-10(17)6-12/h1-6H,(H2,18,19,20) |
| InChi Key | VKVJIWVUYNTBEZ-UHFFFAOYSA-N |
| Smiles | C1=C(C=C(C=C1Cl)Cl)NC(=O)NC2=CC(=CC(=C2)Cl)Cl |
| Isomeric SMILES | C1=C(C=C(C=C1Cl)Cl)NC(=O)NC2=CC(=CC(=C2)Cl)Cl |
| PubChem CID | 595311 |
| 分子量 | 350.03 |
| 溶解性 | DMSO : 125 mg/mL (357.11 mM; Need ultrasonic) |
|---|---|
| 分子量 | 350.000 g/mol |
| XLogP3 | 5.000 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 1 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 349.936 Da |
| 单同位素质量Monoisotopic Mass | 347.939 Da |
| 拓扑极表面积Topological Polar Surface Area | 41.100 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 294.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |